FDA Inspection 1267709 — Eurofins Pharmaceutical Product Testing Belgium NV
The FDA completed an inspection of Eurofins Pharmaceutical Product Testing Belgium NV on Mar 21, 2025 in Nazareth. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 21, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nazareth (Belgium)